Myriad Genetics Stock Price (NASDAQ:MYGN)

Add to My Stocks
$18.33 $0.58 (3.27%) MYGN stock closing price Apr 25, 2017 (Closing)
YOUR DAILY UPDATE ON
MYGN
Myriad Genetics
25 APR 2017
amigobulls logo
MYGN hand_up
MYGN vs S&P 500
Closing Price: Apr 25, 2017
MYGN
$18.33 ( 3.27%)
S&P 500
2388.6 ( 0.61%)
MYGN
52 Week Price Range
1 Year Return: -52.09%
Q2 Growth*
Poor
Profitable ?
Yes
net image
2017 Q2 Net Profit
8.1%
PE Valuation
Cheaper*
home image
Rating
MYGN EXCELLENT
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Myriad Genetics Snapshot Video

13 5 2

MYGN Stock Details

Prev Close* : $17.75
Market Cap:
$1.21B
Day Low: $17.76
52 Week Low: $15.15
Open: $17.84
Volume: 1301870
Day High: $18.5
52 Week High: $37.83
Dividend:
N/A

Latest Stock Market News

Latest Articles

Myriad Genetics News - From Partners

MYGN Stockcharts

View MYGN PE ratio, PS ratio stocks charts and compare with peers.
MYGN Chart
Note: Compare Myriad Genetics stock price history with the index and industry peers.

Myriad Genetics Valuation

PE ratio
(price earnings ratio)
22.08
PS ratio (
price to sales ratio
)
1.66
PB ratio (
price to book ratio
)
1.66

Myriad Genetics Returns

ROE
(return on equity)
8%

Myriad Genetics Financial Ratios

Asset Turnover
0.62
Receivables Turnover
7.62
Debt to Equity
0.28

MYGN Industry Peers

Company Price Change (%)
Puma Biotech (PBYI)38.351.05 (2.82%)
Global Blood Therapeutics (GBT)30.50.05 (0.16%)
Foundation Medicine (FMI)33.451 (3.08%)
Oncocyte (OCX)5.950 (0%)
Genomic Health (GHDX)32.781.26 (4%)
Interleukin Genetics (ILIU)0.090.01 (12.5%)
Fulgent Genetic (FLGT)10.590 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Epizyme (EPZM)17.452.55 (17.11%)
Sangamo BioSciences (SGMO)4.750.45 (10.47%)
Fortress Biotech (FBIO)3.570.29 (8.84%)
Idera Pharma (IDRA)2.4350.19 (8.44%)
Achillion Pharma (ACHN)3.480.27 (8.41%)
Revance (RVNC)22.451.55 (7.42%)
Immunomedics (IMMU)5.440.36 (7.08%)
Top gainers from Medical-Biomed-Genetics industry
* As of Apr 26, 2017
CompanyPriceChange (%)
AKARI THERAPTC (AKTX)15.252.24 (12.81%)
The Medicines Company (MDCO)49.112.34 (4.55%)
Kindred Biosciences (KIN)6.850.3 (4.2%)
ALBIREO PHARMA (ALBO)21.610.37 (1.68%)
Repligen (RGEN)34.630.48 (1.37%)
Cara Therapeutics (CARA)16.390.22 (1.32%)
NOVELION THERAP (NVLN)10.090.12 (1.18%)
Top losers from Medical-Biomed-Genetics industry
* As of Apr 26, 2017

Myriad Genetics, Inc. Stock News - Partner Headlines

Myriad Genetics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues753.8M723.1M778.21M613.16M496M
Net Income125.3M80.2M176.22M147.13M112.15M
Total Operating Expense429.7M441.5M394.56M305.53M251.02M
view Myriad Genetics, Inc. income statement
balance sheet20162015201420132012
Total Assets880.5M766.2M823.81M803.82M690.63M
Total Liabilities132.4M104.1M104.81M75.22M54.97M
Shareholders Equity748.1M662.1M718.99M728.59M635.66M
view Myriad Genetics, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-65.4M-40.7M-59.97M-41.02M-28.76M
Net Cash From (Used By) Operating Activities166.3M140.5M190.21M173.86M141.84M
Increase (Decrease) In Prop Plant And Equipment-5M-23.9M-14.27M-11.37M-9.4M
view Myriad Genetics, Inc. cashflow statement

Myriad Genetics Stock Message Board

An investor needs to spend 18.33 to buy MYGN stock, as the closing Myriad Genetics stock price is 18.33. Myriad Genetics market capitalization is 1.21B and it represents the total market value of MYGN stock. Myriad Genetics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Myriad Genetics is worth a lot, it will most likely be reflected in an inflated Myriad Genetics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 1301870 MYGN shares were traded yesterday, and Myriad Genetics stock chart shows that the MYGN stock quote hit a day high of 18.5 and day low of 17.76. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Myriad Genetics stock price history, gives the entire historical data for MYGN stock.